The company has announced its entry into India’s rapidly expanding nutraceuticals and wellness sector with the launch of Neat Everyday, a new consumer wellness brand
Based on the cumulative data from ACHIEVE-1 through ACHIEVE-5, Lilly plans to submit orforglipron for FDA approval for the treatment of type 2 diabetes by the end of the second quarter
Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology
Seasoned governance expert and board leader brings extensive experience in strategic oversight, risk management, and corporate governance across multiple sectors
The launch comes against the backdrop of a significant public health burden
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
The company will present 21 oral and poster presentations spanning investigational and approved therapies
The campaign places renewed focus on a disease that remains incurable despite major scientific advances
Researchers say the results point to a potential shift in how obesity is treated—as a central disease driving multiple conditions, rather than a collection of separate problems
We are building the bridge between complex molecular data and everyday clinical decisions
Subscribe To Our Newsletter & Stay Updated
